Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel-Lindau Disease. JAMA Oncol 2018 Jan 01;4(1):124-126
Date
10/28/2017Pubmed ID
29075773Pubmed Central ID
PMC5833646DOI
10.1001/jamaoncol.2017.3428Scopus ID
2-s2.0-85041567265 (requires institutional sign-in at Scopus site) 64 CitationsAbstract
This study evaluates the natural history of von Hippel–Lindau disease–associated pancreatic lesions to determine the factors associated with pancreatic neuroendocrine tumor phenotype and prognosis.
Author List
Tirosh A, Sadowski SM, Linehan WM, Libutti SK, Patel D, Nilubol N, Kebebew EMESH terms used to index this publication - Major topics in bold
AdolescentAdult
Child
DNA Mutational Analysis
Disease Progression
Female
Follow-Up Studies
Genetic Association Studies
Genotype
Germ-Line Mutation
Humans
Male
Middle Aged
Neuroendocrine Tumors
Pancreatic Neoplasms
Phenotype
Treatment Outcome
Tumor Burden
Von Hippel-Lindau Tumor Suppressor Protein
Young Adult
von Hippel-Lindau Disease
